RxDoctor Payments Data

Dona Kilgore

Physician Assistant · Tupper Lake, NYNPI 1588976484

Payments from drug & device makers

$773in general payments, 2019–2025

Across 42 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$185
  • Amgen$92
  • GSK$74
  • Astellas Pharma US Inc$69
  • Exact Sciences$67
  • AstraZeneca$60
  • plus $227 from 6 others

What the payments were for

  • Food & beverage$773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$773 in reported general payments places this provider in the 70th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$28,845
Medicare patients
157
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$124,227
EliquisApixaban65$54,096
MounjaroTirzepatide29$29,478
TrulicityDulaglutide29$27,849
JardianceEmpagliflozin30$25,784
FarxigaDapagliflozin Propanediol19$25,250
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$15,293
Tresiba Flextouch U-100Insulin Degludec21$11,251
Combivent RespimatIpratropium/Albuterol Sulfate18$10,711
Incruse ElliptaUmeclidinium Bromide22$10,175
JanuviaSitagliptin Phosphate11$7,891
LinzessLinaclotide14$7,181
Spiriva RespimatTiotropium Bromide12$7,123
MyrbetriqMirabegron11$6,787
Breo ElliptaFluticasone/Vilanterol14$5,356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$185$124,22795 claims
Lilly USA, LLCMounjaro, Trulicity$57$57,32758 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$74$30,82460 claims
AstraZenecaFarxiga$60$25,25019 claims
AbbVieLinzess$54$7,18114 claims
Astellas Pharma US IncMyrbetriq$69$6,78711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Tupper Lake

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →